Schizophrenia Bulletin Advance Access originally published online on April 4, 2007
Schizophrenia Bulletin 2007 33(3):635-641; doi:10.1093/schbul/sbm019
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Is COMT a Susceptibility Gene for Schizophrenia?
2 Department of Psychological Medicine, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK
1 To whom correspondence should be addressed; tel: +44-29-2074-3242, fax: +44-29-2074-6554, e-mail: wpcmod{at}cf.ac.uk.
Catechol-O-methyl transferase (COMT) is a catabolic enzyme involved in the degradation of a number of bioactive molecules; of principal interest to psychiatry, these include dopamine. The enzyme is encoded by the COMT gene. COMT is located (along with 47 other genes) in a fragment of chromosome 22q11 which when deleted results in a complex syndrome, the psychiatric manifestations of which include schizophrenia and other psychoses. These 2 observations have placed COMT near the top of a rather long list of plausible candidate genes for schizophrenia. The ability to test the hypothesis that COMT might be a susceptibility gene for schizophrenia has been simplified in principle by the existence of a valine-to-methionine (Val/Met) polymorphism which results respectively in high and low activity forms of the enzyme. Given the unequivocal effect of this polymorphism on the function of COMT, and the evidence for a critical role for dopamine in the pathophysiology and treatment of psychosis, there are strong prior expectations that Val/Met influences susceptibility to schizophrenia as well as other psychiatric phenotypes. Indeed the Val/Met polymorphism has become the most widely studied polymorphism in psychiatry. In this review, we consider the evidence for and against the involvement of COMT in schizophrenia. The current data allow us to virtually exclude a simple relationship between schizophrenia and the Val/Met variant previously thought to dominate COMT function. However, recent data suggest a more complex pattern of genetic regulation of COMT function beyond that attributable to the Val/Met locus. Moreover, it is also clear that there is a complex nonlinear relationship between dopamine availability and brain function. These 2 factors, allied to phenotypic complexity within schizophrenia, make it difficult to draw strong conclusions regarding COMT in schizophrenia. Nevertheless, emerging research that takes greater account of all these levels of complexity is beginning to provide tantalizing, but far from definitive, support for the view that COMT influences susceptibility to at least some forms of psychosis.
Keywords: schizophrenia / COMT / prefrontal cortex / association / cognition / psychosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. B. Quednow, M. Wagner, R. Mossner, W. Maier, and K.-U. Kuhn Sensorimotor Gating of Schizophrenia Patients Depends on Catechol O-Methyltransferase Val158Met Polymorphism Schizophr Bull, July 17, 2008; (2008) sbn088v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Pearlson and B. S. Folley Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework Schizophr Bull, July 1, 2008; 34(4): 722 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Talkowski, G. Kirov, M. Bamne, L. Georgieva, G. Torres, H. Mansour, K. V. Chowdari, V. Milanova, J. Wood, L. McClain, et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia Hum. Mol. Genet., March 1, 2008; 17(5): 747 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Williams, B. Glaser, N. Norton, H. Williams, T. Pierce, V. Moskvina, S. Monks, J. Del Favero, D. Goossens, D. Rujescu, et al. Strong evidence that GNB1L is associated with schizophrenia Hum. Mol. Genet., February 14, 2008; 17(4): 555 - 566. [Abstract] [Full Text] [PDF]
|
|